Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.4 has been added, replacing the previous revision label v3.5.3. This reflects a site version update without altering substantive study information.SummaryDifference0.1%

- Check8 days agoChange DetectedThe related topics section no longer lists 'Rheumatoid arthritis' or the 'MedlinePlus Genetics' link, reducing disease-specific context and related resources on the page.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s displayed revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change to the site build rather than the study record.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded related topics on the page: Rheumatoid arthritis and MedlinePlus Genetics.SummaryDifference0.2%

- Check59 days agoChange DetectedAdded Revision: v3.5.0; removed Rheumatoid arthritis, related topics: MedlinePlus Genetics, and Revision: v3.4.3.SummaryDifference0.3%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.